1. |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin, 2017, 67(1): 7-30.
|
2. |
杜潇, 赵玉沛. 胰腺发育和胰腺癌中 Notch 信号通路作用的研究进展. 中国普外基础与临床杂志, 2010, 17(10): 1109-1112.0.
|
3. |
王晓辉, 李非. 胰腺癌干细胞的研究进展. 中国普外基础与临床杂志, 2011, 18(9): 931-935.0.
|
4. |
Jesnowski R, Isaksson B, Möhrcke C, et al. Helicobacter pylori in autoimmune pancreatitis and pancreatic carcinoma. Pancreatology, 2010, 10(4): 462-466.
|
5. |
张德奎, 李玉民. 胰腺癌的内镜诊治进展. 中国普外基础与临床杂志, 2010, 17(10): 1027-1031.0.
|
6. |
Becker AE, Hernandez YG, Frucht H, et al. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. World J Gastroenterol, 2014, 20(32): 11182-11198.
|
7. |
Cover TL. Perspectives on methodology for in vitro culture of Helicobacter pylori. Methods Mol Biol, 2012, 921: 11-15.
|
8. |
Noto JM, Peek RM Jr. Helicobacter pylori: an overview. Methods Mol Biol, 2012, 921: 7-10.
|
9. |
Engstrand L, Lindberg M. Helicobacter pylori and the gastric microbiota. Best Pract Res Clin Gastroenterol, 2013, 27(1): 39-45.
|
10. |
Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet, 1984, 1(8390): 1311-1315.
|
11. |
Alakkari A, Zullo A, O’Connor HJ. Helicobacter pylori and nonmalignant diseases. Helicobacter, 2011, 16 Suppl 1: 33-37.
|
12. |
Venerito M, Vasapolli R, Malfertheiner P. Helicobacter pylori and gastric cancer: Timing and impact of preventive measures. Adv Exp Med Biol, 2016, 908: 409-418.
|
13. |
Rabelo-Gonçalves EM, Roesler BM, Zeitune JM. Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases. World J Hepatol, 2015, 7(30): 2968-2979.
|
14. |
Schulte A, Pandeya N, Fawcett J, et al. Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis. Cancer Causes Control, 2015, 26(7): 1027-1035.
|
15. |
Huang J, Zagai U, Hallmans G, et al. Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study. Int J Cancer, 2017, 140(8): 1727-1735.
|
16. |
Chen XZ, Wang R, Chen HN, et al. Cytotoxin-associated gene A-negative strains of Helicobacter pylori as a potential risk factor of pancreatic cancer: A meta-analysis based on nested case-control studies. Pancreas, 2015, 44(8): 1340-1344.
|
17. |
Chen XZ, Schöttker B, Castro FA, et al. Association of Helicobacter pylori infection and chronic atrophic gastritis with risk of colonic, pancreatic and gastric cancer: A ten-year follow-up of the ESTHER cohort study. Oncotarget, 2016, 7(13): 17182-17193.
|
18. |
Bulajic M, Panic N, Löhr JM. Helicobacter pylori and pancreatic diseases. World J Gastrointest Pathophysiol, 2014, 5(4): 380-383.
|
19. |
李庆东, 匡毅, 邓和军. 胰腺癌与幽门螺杆菌感染相关性研究. 中华医院感染学杂志, 2014, 24(23): 5861-5863.0.
|
20. |
Venerito M, Vasapolli R, Rokkas T, et al. Helicobacter pylori and gastrointestinal malignancies. Helicobacter, 2015, 20 Suppl 1: 36-39.
|
21. |
Ai F, Hua X, Liu Y. Preliminary study of pancreatic cancer associated with Helicobacter pylori infection. Cell Biochem Biophys, 2015, 71(1): 397-400.
|
22. |
Risch HA, Yu H, Lu L, et al. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst, 2010, 102(7): 502-505.
|
23. |
Lindkvist B, Johansen D, Borgström A, et al. A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer. BMC Cancer, 2008, 8: 321.
|
24. |
de Martel C, Llosa AE, Friedman GD, et al. Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol Biomarkers Prev, 2008, 17(5): 1188-1194.
|
25. |
Risch HA, Lu L, Wang J, et al. ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis. Am J Epidemiol, 2013, 177(12): 1326-1337.
|
26. |
Lochan R, Daly AK, Reeves HL, et al. Family history of cancer and tobacco exposure in index cases of pancreatic ductal adenocarcinoma. J Oncol, 2011, 2011: 215985.
|
27. |
Yeo TP, Lowenfels AB. Demographics and epidemiology of pancreatic cancer. Cancer J, 2012, 18(6): 477-484.
|
28. |
Bracci PM. Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms. Mol Carcinog, 2012, 51(1): 53-63.
|
29. |
Cover TL, Peek RM Jr. Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer. Gut Microbes, 2013, 4(6): 482-493.
|
30. |
Takayama S, Takahashi H, Matsuo Y, et al. Effects of Helicobacter pylori infection on human pancreatic cancer cell line. Hepatogastroenterology, 2007, 54(80): 2387-2391.
|
31. |
陈佳慧, 肖江卫, 任明扬, 等. gastrokine 1 在胃癌组织中的表达及其与胃癌临床病理特征的关系.中国普外基础与临床杂志, 2012, 19(10): 1089-1093.0.
|
32. |
Lee SW, Chang CS, Lee TY, et al. Risk factors and therapeutic response in Chinese patients with peptic ulcer disease. World J Gastroenterol, 2010, 16(16): 2017-2022.
|
33. |
Sokic-Milutinovic A, Krstic M, Rozer-Smolovic B, et al. Role of Helicobacter pylori infection in gastroduodenal damage in patients starting NSAID therapy: 4 months follow-up study. Dig Dis Sci, 2010, 55(10): 2887-2892.
|
34. |
葛均波, 徐永健. 内科学. 第 8 版. 北京: 人民卫生出版社, 2013.
|
35. |
乔竹风. 胰腺癌与幽门螺杆菌感染相关性初步分析. 贵阳医学院学报, 2012, 37(4): 411-413.0.
|
36. |
Risch HA. Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J Natl Cancer Inst, 2003, 95(13): 948-960.
|
37. |
Nilsson HO, Stenram U, Ihse I, et al. Helicobacter species ribosomal DNA in the pancreas, stomach and duodenum of pancreatic cancer patients. World J Gastroenterol, 2006, 12(19): 3038-3043.
|
38. |
杨雷, 孙学军, 王炜, 等. MCP-1、VEGF 在胃癌中的表达与幽门螺旋杆菌感染的关系. 中国普外基础与临床杂志, 2009, 16(5): 375-378.0.
|
39. |
李健. 胃肠间质瘤诊治的发展历程与方向. 中国普外基础与临床杂志, 2017, 24(2): 137-140.0.
|
40. |
邓勇, 曾维琼, 詹柱, 等.幽门螺杆菌感染与胰腺癌相关性的累积 Meta 分析.重庆医学,2015,44(32):4549-45520.
|
41. |
Rieder G, Karnholz A, Stoeckelhuber M, et al. H pylori infection causes chronic pancreatitis in Mongolian gerbils. World J Gastroenterol, 2007, 13(29): 3939-3947.
|